Joshua D Grill

Photo of Joshua D Grill
Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-5905
vCardDownload vCard
    Other Positions
    Title(s)Professor, Neurobiology & Behavior


    Collapse Overview 
    Collapse overview
    Our laboratory is devoted to translational neuroscience in Alzheimer’s disease and related disorders, particularly the science of clinical trial design, recruitment, retention and disclosure. We are part of the UC Irvine Institute for Memory Impairments and Neurological Disorders and the UC Irvine Alzheimer’s Disease Research Center.

    Collapse Biography 
    Collapse education and training
    Miami University, Oxford, OH05/1999Psychology and Zoology, Neuroscience (minor)
    Wake Forest University School of Medicine, Winston-Salem, NCPhD08/2004Neuroscience
    National Institute of Neurologic Disorders and Stroke Research Methods in Clinical Trials Cours, Vail, CO08/2009clinical trials
    UCLA K30 Translational Research Training Program, Westwood, CA08/2012clinical research

    Collapse Research 
    Collapse research activities and funding
    Discovery and Trial Ready Cohort for Limbic Predominant Age Related TDP-43 Encephalopathy (TRC LATE)
    NIH R01AG095017Sep 1, 2025 - Jun 30, 2030
    Role: Co-Principal Investigator
    Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders Research and Education (CARE) 2.0
    NIH R01AG083926Aug 1, 2023 - Jun 30, 2028
    Role: Co-Investigator
    Patient and Family Member Reactions to Biomarker-Informed ADRD Diagnoses
    NIH R01AG080591Mar 1, 2023 - Feb 28, 2028
    Role: Co-Principal Investigator
    Patient and Family Member Reactions to Biomarker-Informed ADRD Diagnoses
    NIH RF1AG080591Mar 1, 2023 - Feb 28, 2026
    Role: Co-Investigator
    Recruiting multiethnic populations to preclinical Alzheimers disease trials
    NIH R21AG074371Aug 15, 2022 - Apr 30, 2025
    Role: Principal Investigator
    Summer Medical student Aging and Alzheimer disease Research Training (SMAART) program
    NIH T35AG076424Jun 1, 2022 - May 31, 2027
    Role: Co-Investigator
    NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course)
    NIH R25AG076392Jun 1, 2022 - Mar 31, 2027
    Role: Co-Investigator
    Recruiting and retaining participants from disadvantaged neighborhoods in registries
    NIH R01AG077628May 1, 2022 - Jan 31, 2027
    Role: Principal Investigator
    Training in Translational ADRD Neuroscience (TITAN)
    NIH T32AG073088Sep 1, 2021 - Aug 31, 2026
    Role: Principal Investigator
    Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) Alumni Scholar Conference
    NIH R13AG067696Aug 1, 2020 - Apr 30, 2030
    Role: Co-Principal Investigator
    The Alzheimer's Disease Research Center at the University of California, Irvine
    NIH P30AG066519Jun 15, 2020 - Mar 31, 2030
    Role: Principal Investigator
    Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD) Course
    NIH U13AG067696Jun 1, 2020 - May 31, 2025
    Role: Co-Principal Investigator
    Effects of Alzheimer's disease clinical trial study partners
    NIH RF1AG059407May 15, 2018 - Apr 30, 2022
    Role: Principal Investigator
    The study partner requirement in preclinical Alzheimers disease trials
    NIH R21AG056931Sep 15, 2017 - May 31, 2020
    Role: Principal Investigator
    UCLA NEXT Collaboration Site
    NIH U10NS077355Sep 30, 2011 - Jun 30, 2020
    Role: Co-Principal Investigator
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Beyond Binary-The Case for Amyloid Centiloid Quantification. JAMA. 2026 Jul 21; 336(3):191-192. Chin NA, Erickson CM, Grill JD, Rabinovici GD. PMID: 42307963.
      View in: PubMed   Mentions:    Fields:    
    2. The Promise and Peril of Alzheimer Disease Prevention. Neurology. 2026 Aug 11; 107(3):e218348. Grill JD, Graff-Radford J. PMID: 42467872; PMCID: PMC13382872.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Ceperognastat in Alzheimer Disease: Lessons From a Negative Clinical Trial. JAMA. 2026 Jul 13. Rabinovici GD, Grill JD. PMID: 42441398.
      View in: PubMed   Mentions:    Fields:    
    4. Hippocampal asymmetry captures non-amyloid-related risk of memory decline and clinical progression. J Prev Alzheimers Dis. 2026 Jul 06; 13(8):100638. Ghanbarian E, Khorsand B, Zheng L, Woodworth DC, Glover CM, Corrada MM, Sajjadi SA, Grill JD, Ezzati A, Alzheimer’s Disease Neuroimaging Initiative. PMID: 42407430; PMCID: PMC13355404.
      View in: PubMed   Mentions:    Fields:    
    5. Eligibility of men vs. women in Alzheimer's trials: Inclusive vs. representative. J Prev Alzheimers Dis. 2026 Aug; 13(7):100625. Grill JD, Gillen DL. PMID: 42287775; PMCID: PMC13279289.
      View in: PubMed   Mentions:    Fields:    
    6. APOE and amyloid-tau pathology in cognitively unimpaired older adults. medRxiv. 2026 Jun 03. Morillo CA, Zheng L, Ghanbarian E, Khorsand B, Glover CM, Grill JD, Sajjadi SA, Alzheimer’s Disease Neuroimaging Initiative, Ezzati A. PMID: 42282183; PMCID: PMC13252495.
      View in: PubMed   Mentions:
    7. A plasma protein signature for cerebral amyloid angiopathy. Acta Neuropathol. 2026 May 20; 151(1). Singh A, Denkinger MN, Leuzy A, Dieckhoff K, Liu J, Marques TM, Monuki E, Stark C, Grill JD, Hom C, Sultzer D, Doran E, Lott I, Wood K, Gawronski B, Gonzalez L, Choudhury P, Atri A, Beach TG, Serrano GE, Sajjadi SA, Van Keuren-Jensen K, Reiman EM, Head E, Ashton NJ. PMID: 42162487; PMCID: PMC13190554.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. CSF p-tau Predicts Asymmetric Hippocampal Atrophy in Cognitively Unimpaired Older Adults. medRxiv. 2026 May 06. Ghanbarian E, Zheng L, Qian T, Glover CM, Sajjadi SA, Corrada MM, Grill JD, Alzheimer’s Disease Neuroimaging Initiative, Ezzati A. PMID: 42145631; PMCID: PMC13174718.
      View in: PubMed   Mentions:
    9. Scalable markers for early cognitive decline: Plasma p-tau217, subjective cognitive concerns, and digital testing: Results from the A4/LEARN studies. Alzheimers Dement. 2026 May; 22(5):e71505. Khorsand B, Teichrow D, Ghanbarian E, Zheng L, Sajjadi SA, Glover CM, Grill JD, Rabin LA, Ezzati A. PMID: 42204876; PMCID: PMC13240426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Interrupted Time Series Methods for Nonrandom Sampling Study Designs With Known Sampling Weights. Stat Med. 2026 May; 45(10-12):e70560. Lu TV, Grill JD, Gillen DL, Cruz M. PMID: 42144889.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer's Disease Research Centers: Current strategies and future directions. Alzheimers Dement. 2026 Apr; 22(4):e71238. Chan CK, Glover CM, Parker M, Grill JD, Langbaum JB, Morhardt DJ, Okonkwo O, Farrar-Edwards D, Wang S. PMID: 42028802; PMCID: PMC13107418.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup. Alzheimers Dement. 2026 Apr; 22(4):e71361. van Etten ES, Mahinrad S, Grill JD, Salloway S, Atri A, Cogswell PM, Benzinger TLS, Iwatsubo T, Iadecola C, Lemere CA, Nicoll JAR, Greenberg SM, Carrillo MC, Jack CR, Sperling RA. PMID: 42015334; PMCID: PMC13099593.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress. JAMA Netw Open. 2026 Mar 02; 9(3):e263845. Grill JD, Raman R, Wang S, Ernstrom K, Andrews PS, Appleby BS, Bhangu J, Dhadda S, Irizarry M, Johnson K, Lenio S, MacDonald S, Ramanan VK, Rosenberg PB, Weisman D, Aisen P, Sperling R, Sultzer D, Karlawish J. PMID: 41910973; PMCID: PMC13036580.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026 Mar; 25(3):268-278. Reiman EM, Alexander RC, Langbaum JB, Aisen PS, Ashton N, Atri A, Barbarino P, Byrd GS, Feldman HH, Fowler NR, Ghisays V, Grill JD, Hassenstab J, Heaton GR, Herring WL, Jack CR, Johnson SC, Karlawish J, Keach NL, Kivipelto M, Krumholz HM, Largent EA, MaGee-Rodgers T, McDade E, Mielke MM, Molina-Henry D, Petersen RC, Rabinovici GD, Ritchie C, Schindler SE, Sperling RA, Suárez-Calvet M, Vradenburg G, Weiner MW, Welsh-Bohmer KA, Zetterberg H, Zuendel MT, Mattke S, Cummings JL. PMID: 41722593.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Uniform Amyloid Thresholds Across Populations. JAMA Neurol. 2026 Mar 01; 83(3):296-299. Vanderlip CR, Gillen DL, Stark CEL, Grill JD, HABS-HD Study Team. PMID: 41557361; PMCID: PMC12820775.
      View in: PubMed   Mentions:    Fields:    
    16. Cognitive screening biases in a secondary prevention Alzheimer's disease clinical trial. Alzheimers Dement. 2026 Mar; 22(3):e71254. Sai I, Grill JD, Younes K, Winer JR, Cody KA, Sperling R, Mormino EC, Young CB. PMID: 41778849; PMCID: PMC12958866.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer's trials. J Prev Alzheimers Dis. 2026 Apr; 13(4):100503. Vanderlip CR, Gillen DL, Grill JD, Stark CEL. PMID: 41653883; PMCID: PMC12907085.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Hippocampal Asymmetry Captures Non-Amyloid-Related Risk of Memory Decline and Clinical Progression. medRxiv. 2026 Jan 08. Ghanbarian E, Khorsand B, Zheng L, Woodworth DC, Glover CM, Corrada MM, Grill JD, Sajjadi SA, Alzheimer’s Disease Neuroimaging Initiative, Ezzati A. PMID: 41542671; PMCID: PMC12803399.
      View in: PubMed   Mentions:
    19. Blood Tests for Alzheimer Disease-What to Do With the Holy Grail. JAMA Neurol. 2026 Jan 01; 83(1):11-12. Grill JD. PMID: 41324931.
      View in: PubMed   Mentions:    Fields:    
    20. Cognitive screening biases in a secondary prevention Alzheimer's disease clinical trial. medRxiv. 2025 Dec 04. Sai I, Grill JD, Younes K, Winer JR, Cody KA, Sperling R, Mormino EC, Young CB. PMID: 41409674; PMCID: PMC12706604.
      View in: PubMed   Mentions:
    21. Disclosing Alzheimer Biomarkers to Motivate Brain Health Behaviors. JAMA Netw Open. 2025 Dec 01; 8(12):e2545780. Grill JD. PMID: 41324966.
      View in: PubMed   Mentions:    Fields:    
    22. Current evidence of randomized clinical trials on hospice-eligible patients with agitation and dementia: A narrative review. Palliat Support Care. 2025 Nov 27; 23:e209. Wang OY, Calev N, Mintzer J, Fritts A, Molina-Henry DP, Grill JD, Raman R. PMID: 41305862; PMCID: PMC12926728.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1. Lancet Healthy Longev. 2025 Nov; 6(11):100778. Langbaum JB, Bradbury AR, Egleston BL, McCarty Wood E, Langlois CM, Largent EA, Harkins K, Erickson CM, Stites SD, Oyen E, Riviere ME, Liu F, Graf A, Kim SYH, Grill JD, Reiman EM, Tariot PN, Roberts JS, Karlawish J. PMID: 41319675; PMCID: PMC12703885.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Prognostic value of plasma glial fibrillary acidic protein in cognitively unimpaired older adults: Results from the A4 study. Alzheimers Dement. 2025 11; 21(11):e70948. Ghanbarian E, Qian T, Khorsand B, Zheng L, Sajjadi SA, Grill JD, Rabin LA, Lipton RB, Sperling RA, Ezzati A. PMID: 41268784; PMCID: PMC12635861.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Alzheimer's Disease Clinical Trial Decision-Making Among Patients with Mild Cognitive Impairment and Their Study Partners. AJOB Empir Bioeth. 2025 Oct-Dec; 16(4):277-285. Cox CG, Birnbaum AI, Salazar CR, Witbracht M, Tam SP, Thai GT, Sajjadi SA, Gillen DL, Grill JD. PMID: 41147833; PMCID: PMC12593232.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Scalable Markers for Early Cognitive Decline: Plasma p-tau217, Subjective Cognitive Concerns, and Digital Testing: Results from the A4/LEARN studies. medRxiv. 2025 Oct 15. Khorsand B, Teichrow D, Ghanbarian E, Zheng L, Sajjadi SA, Glover CM, Grill JD, Rabin LA, Ezzati A. PMID: 41282720; PMCID: PMC12633133.
      View in: PubMed   Mentions:
    27. Recruitment and retention in a preclinical AD trial: comparisons between academic and non-academic sites. Alzheimers Res Ther. 2025 10 14; 17(1):222. Ritchie M, Hussen K, Langford O, Navarro C, Kotadiya Z, Donohue MC, Aisen P, Sperling RA, Grill JD, Raman R. PMID: 41088262; PMCID: PMC12522582.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Prognostic Value of Plasma Glial Fibrillary Acidic Protein in Cognitively Unimpaired Older Adults: Results from the A4 Study. medRxiv. 2025 Aug 29. Ghanbarian E, Qian T, Khorsand B, Zheng L, Sajjadi SA, Grill JD, Rabin LA, Lipton RB, Sperling RA, Ezzati A. PMID: 40909823; PMCID: PMC12407660.
      View in: PubMed   Mentions:
    29. Characterizing the Research Participant Recruitment Funnel for Alzheimer's Secondary Prevention Trials: Results from A National Survey of U.S. Adults. Alzheimers Dement Behav Socioecon Aging. 2025 Sep; 1(3). Largent EA, Grill JD, Karlawish J, Bleakley A. PMID: 40937435; PMCID: PMC12422305.
      View in: PubMed   Mentions:
    30. Racial and ethnic differences in plasma p-tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab. Alzheimers Dement (Amst). 2025 Jul-Sep; 17(3):e70164. Molina-Henry DP, Raman R, Liu A, Langford O, Braunstein JB, Verghese PB, Venkatesh V, Dhadda S, Irrizary M, Grill JD, Johnson K, Rissman RA, Aisen P, Sperling RA, AHEAD 3-45 Study Team. PMID: 40861822; PMCID: PMC12371446.
      View in: PubMed   Mentions: 2  
    31. Late-life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals. Alzheimers Dement. 2025 08; 21(8):e70619. Kim TH, Head E, Stark CEL, Sordo L, Kirby KA, Corona MG, McDonnell M, Grill JD, Sultzer DL. PMID: 40851415; PMCID: PMC12375875.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Alzheimer's Disease Research Center Down Syndrome Cores: Experience from two sites. Alzheimers Dement. 2025 08; 21(8):e70612. Ptomey L, Hom C, Wilkins H, Doran E, Wright ST, Hoang D, Delehoy B, Lott IT, Perales-Puchalt J, Helsel B, Burns J, Grill JD, Head E. PMID: 40847661; PMCID: PMC12374163.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives. Alzheimers Dement. 2025 08; 21(8):e70536. Iwatsubo T, Sperling RA, Algeciras-Schimnich A, Arai H, Barron AM, Benzinger TLS, Carrillo MC, Chen C, Choi SH, Fontana IC, Graff-Radford J, Grill JD, Heidebrink J, Hu CJ, Ihara R, Ikeuchi T, Iwata A, Ip FCF, Fitri FI, Jack CR, Jeong JH, Jia J, Kandiah N, Kim S, Kowa H, La Joie R, Niimi Y, Noritake R, Okonkwo OC, Palmqvist S, Rafii MS, Raman R, Shen Y, Simuni T, Snyder HM, Sriwannopas O, Stoeckel LE, van der Flier WM, Wang H, Wilcock DM, Zetterberg H, Zhou J, Mahinrad S, Sexton CE. PMID: 40760693; PMCID: PMC12321508.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Effectiveness of a local recruitment registry in older adults in Southern California. BMC Med Res Methodol. 2025 07 31; 25(1):181. Birnbaum AI, Gombosev A, Grant-Freeman ZT, Hoang D, Gillen DL, Grill JD. PMID: 40745267; PMCID: PMC12315308.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. It is time to share Alzheimer biomarker results in dementia with Lewy bodies. Alzheimers Dement (Amst). 2025 Jul-Sep; 17(3):e70144. Armstrong MJ, Grill JD, Tropea TF. PMID: 40636063; PMCID: PMC12238827.
      View in: PubMed   Mentions: 1  
    36. Five years of the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD). Alzheimers Dement. 2025 07; 21(7):e70441. Grill JD, Mastrolorenzo MD, Snyder HM, Carrillo MC, Petersen RC, Aisen P, Sperling R, Hussen K, Raman R. PMID: 40660743; PMCID: PMC12260129.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Estimating the optimal cutoff for the IGT-AD Distress subscale adapted for amyloid PET results disclosure. Alzheimers Dement (N Y). 2025 Apr-Jun; 11(2):e70116. Ren D, Eun KJ, Grill JD, Lingler JH. PMID: 40486075; PMCID: PMC12144969.
      View in: PubMed   Mentions:
    38. Association of Alzheimer's disease concerns with amyloid burden and lifestyle behaviors in cognitively unimpaired older adults. Alzheimers Dement. 2025 06; 21(6):e70225. Farina FR, Bennett M, Grill JD, Sperling R, Lawlor B, Griffith JW. PMID: 40476544; PMCID: PMC12142429.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Understanding participants' attitudes toward research in the CARE registry. Alzheimers Dement. 2025 06; 21(6):e70372. Hoffmann TJ, Tsoh JY, Meyer OL, Tzuang M, Nam B, Fara-On G, Huang D, Kanaya AM, Gallagher-Thompson D, Vuong Q, Shin HW, Tofaeono V, Grill JD, Park VT. PMID: 40545557; PMCID: PMC12183098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Aligning Alzheimer Disease Biology With Care. JAMA Neurol. 2025 Jun 01; 82(6):537-538. Ketchum FB, Chin NA, Grill JD. PMID: 39928326; PMCID: PMC13402869.
      View in: PubMed   Mentions: 1     Fields:    
    41. The Bad Medicine of Doctored. JAMA. 2025 May 27; 333(20):1771-1772. Grill JD, Rabinovici GD. PMID: 40095593; PMCID: PMC13055475.
      View in: PubMed   Mentions:    Fields:    
    42. The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer's disease based solely on biomarker evidence. Alzheimers Dement. 2025 Apr; 21(4):e70068. Planche V, Schindler S, Knopman DS, Frisoni G, Galasko D, Grill JD, Schneider L, Karlawish J, Villain N. PMID: 40243238; PMCID: PMC12004391.
      View in: PubMed   Mentions: 5     Fields:    
    43. Increasing representation of Asian American, Native Hawaiian, and Pacific Islander communities in aging, dementia, and caregiving research: An update from the CARE registry. Alzheimers Dement. 2025 04; 21(4):e70144. Grill JD, Tsoh JY, Nam B, Tzuang M, Huang D, Fara-On G, Johnson CB, Hoffmann TJ, Meyer OL, Mukherjea A, Nishita C, Gallagher-Thompson D, Hinton L, Tofaeono V, Balaz P, Tavana JP, Tiet QQ, Javier JR, Vuong Q, Park VT. PMID: 40207420; PMCID: PMC11982931.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    44. Virtual Data Collection Strategies in Research on Alzheimer's Disease and Related Dementias (ADRD). Innov Aging. 2025; 9(5):igaf026. Kim JE, Knox M, Grill JD, Witbracht M, Zhang Y, Salazar H, Garrett M, Russ E, Medina M, Lingler JH. PMID: 40454424; PMCID: PMC12123064.
      View in: PubMed   Mentions: 1  
    45. Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer's disease. Alzheimers Res Ther. 2025 03 11; 17(1):59. Ketron GL, Grun F, Grill JD, Feldman HH, Rissman RA, Brewer GJ. PMID: 40069789; PMCID: PMC11895359.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    46. Impact of study partner replacement in a mild cognitive impairment clinical trial. Alzheimers Dement (N Y). 2025 Jan-Mar; 11(1):e70063. Dolmadjian LA, Baumann MR, Grill JD, Gillen DL. PMID: 40017898; PMCID: PMC11865708.
      View in: PubMed   Mentions:
    47. Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial. Alzheimers Dement. 2025 02; 21(2):e14623. Grill JD, Raman R, Flournoy C, Ernstrom K, Pierce A, Smith A, Rosenberg P, Burns J, Karlawish J, Aisen P, Holdridge KC, Mancini M, Sperling R, Sultzer D, A4 Study Team. PMID: 39988989; PMCID: PMC11847990.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: the need for rigor. Alzheimers Res Ther. 2025 02 01; 17(1):32. Grill JD, Gillen D. PMID: 39893378; PMCID: PMC11786341.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Research Attitudes Questionnaire scores and retention in a recruitment registry. J Alzheimers Dis. 2025 01; 103(2):406-418. Witbracht M, Xu Y, Morgan OB, Salazar CR, Hoang D, Kind A, Gillen DL, Grill JD. PMID: 39814522.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease. Neurology. 2025 Jan 14; 104(1):e210152. Grill JD, Tam S, Thai G, Vides B, Pierce AL, Green K, Gillen DL, Teng E, Kremen S, Beigi M, Rissman RA, Léger GC, Balasubramanian A, Revta C, Morrison R, Jennings R, Pa J, Zhang J, Jin S, Messer K, Feldman HH. PMID: 39671543; PMCID: PMC11655133.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    51. Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2024 Oct-Dec; 10(4):e70009. Nishida MK, Nuño MM, Grill JD, Gillen DL. PMID: 39748852; PMCID: PMC11694524.
      View in: PubMed   Mentions: 1  
    52. Alzheimer's disease biomarkers and the tyranny of treatment. EBioMedicine. 2024 Oct; 108:105291. Karlawish J, Grill JD. PMID: 39366841; PMCID: PMC11663781.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    53. Centers for Medicare and Medicaid Services Coverage of Amyloid PET. JAMA Neurol. 2024 Sep 01; 81(9):903-904. Grill JD, Lingler JH. PMID: 39008283.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Community recruitment of underrepresented populations to the AHEAD 3-45 preclinical AD trial using novel partnerships with nursing and community-based organizations: Lessons and outcomes. Alzheimers Dement. 2024 10; 20(10):7160-7173. Salazar CR, Tallakson M, Corona MG, Duran E, Russ E, Hoang D, Romero RA, Sultzer DL, Grill JD, Shin HW. PMID: 39210635; PMCID: PMC11485091.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Comparing research attitudes in Down syndrome and non-Down syndrome research decision-makers. Alzheimers Dement (N Y). 2024 Jul-Sep; 10(3):e12478. Lu TV, Campos P, Leader S, Lee X, Xu H, Doran E, Grill JD, Lott IT. PMID: 39086735; PMCID: PMC11289724.
      View in: PubMed   Mentions: 2  
    56. The utility of recruitment incentives in early Alzheimer's disease trials. Alzheimers Dement. 2024 09; 20(9):6654-6658. Ritchie M, Witbracht M, Russ E, Sajjadi SA, Thai GT, Tam S, Gillen DL, Grill JD. PMID: 39072914; PMCID: PMC11497734.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study. Alzheimers Dement. 2024 09; 20(9):6060-6069. Magana-Ramirez CM, Irizarry-Martinez G, Gillen DL, Grill JD. PMID: 39041310; PMCID: PMC11497770.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial. Alzheimers Dement. 2024 08; 20(8):5450-5459. Greysen SR, Oon AL, Harkins K, Rareshide C, Mondal A, Patel MS, Grill JD, Karlawish J. PMID: 38962958; PMCID: PMC11350015.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial. Alzheimers Dement. 2024 06; 20(6):3827-3838. Molina-Henry DP, Raman R, Liu A, Langford O, Johnson K, Shum LK, Glover CM, Dhadda S, Irizarry M, Jimenez-Maggiora G, Braunstein JB, Yarasheski K, Venkatesh V, West T, Verghese PB, Rissman RA, Aisen P, Grill JD, Sperling RA. PMID: 38629508; PMCID: PMC11180863.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    60. Vietnamese American Perspectives on Engagement in an Aging-Focused Research Registry. Dement Geriatr Cogn Disord. 2024; 53(2):83-90. Meyer OL, Nguyen K, Nam B, Tsoh JY, Hinton L, Gallagher-Thompson D, Grill J, Vuong Q, Park VT. PMID: 38422998; PMCID: PMC11073895.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Post-disclosure distress among racial and ethnic groups in a preclinical AD trial. Alzheimers Dement. 2024 04; 20(4):2508-2515. Ritchie M, Salazar CR, Gillen DL, Grill JD. PMID: 38329007; PMCID: PMC11032552.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Examining Utilization of Formal Supports and Related Impacts on Overall Well-Being Among East Asian American Family Caregivers of Persons With Dementia: A Mixed-Methods Study. Gerontologist. 2024 02 01; 64(2). Lee K, Cassidy J, Lee J, Seo CH, Kunz Lomelin A, Shin HW, Grill JD. PMID: 37394998; PMCID: PMC11491536.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial. Neurol Clin Pract. 2024 Apr; 14(2):e200265. Grill JD, Raman R, Ernstrom K, Wang S, Donohue MC, Aisen PS, Karlawish J, Henley D, Romano G, Novak G, Brashear HR, Sperling RA. PMID: 38585443; PMCID: PMC10996909.
      View in: PubMed   Mentions: 10  
    64. Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. Neurol Clin Pract. 2024 Apr; 14(2):e200230. Ritchie M, Sajjadi SA, Grill JD. PMID: 38223345; PMCID: PMC10783973.
      View in: PubMed   Mentions: 13  
    65. Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials. J Alzheimers Dis. 2024; 98(2):729-738. Lu TV, Grill JD, Gillen DL, Alzheimer’s Disease Cooperative Study. PMID: 38427487; PMCID: PMC10977362.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial. J Prev Alzheimers Dis. 2024; 11(6):1563-1571. Ritchie M, Raman R, Ernstrom K, Wang S, Donohue MC, Aisen P, Henley D, Romano G, Novak GP, Brashear HR, Sperling RA, Grill JD. PMID: 39559869; PMCID: PMC11573807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials. J Prev Alzheimers Dis. 2024; 11(5):1435-1444. Walter S, Langford O, Jimenez-Maggiora GA, Abdel-Latif S, Rissman RA, Grill JD, Karlawish J, Atri A, Bruschi S, Hussen K, Donohue MC, Marshall GA, Jicha G, Racke M, Turner RS, van Dyck CH, Venkatesh V, Yarasheski KE, Sperling R, Cummings J, Aisen PS, Raman R. PMID: 39350391; PMCID: PMC11436450.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Estimating Socio-Economic Status for Alzheimer's Disease Trials. J Prev Alzheimers Dis. 2024; 11(5):1418-1425. Rentz DM, Grill JD, Molina-Henry DP, Jicha GA, Rafii MS, Liu A, Sperling RA, Aisen PS, Raman R. PMID: 39350389; PMCID: PMC11436426.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial. J Prev Alzheimers Dis. 2024; 11(4):874-880. Raman R, Hussen K, Donohue MC, Ernstrom K, Holdridge KC, Langford O, Molina-Henry DP, Pierce AL, Sims JR, Smith A, Yaari R, Aisen PS, Sperling R, Grill JD. PMID: 39044496; PMCID: PMC11266258.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Longitudinal Trajectories of the Cognitive Function Index in the A4 Study. J Prev Alzheimers Dis. 2024; 11(4):838-845. Amariglio RE, Grill JD, Rentz DM, Marshall GA, Donohue MC, Liu A, Aisen PS, Sperling RA. PMID: 39044492; PMCID: PMC11266220.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024; 11(4):802-813. Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD, Heidebrink JL, Jenkins C, Jimenez-Maggiora G, Langford O, Liu A, Raman R, Yaari R, Holdridge KC, Sims JR, Aisen PS. PMID: 39044488; PMCID: PMC11266444.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    72. Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials. J Prev Alzheimers Dis. 2024; 11(3):558-566. Liu H, Li J, Ziegemeier E, Adams S, McDade E, Clifford DB, Cao Y, Wang G, Li Y, Mills SL, Santacruz AM, Belyew S, Grill JD, Snider BJ, Mummery CJ, Surti G, Hannequin D, Wallon D, Berman SB, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sanchez-Valle R, Brooks WS, Gauthier S, Galasko D, Masters CL, Brosch J, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Bateman RJ, Llibre-Guerra JJ. PMID: 38706272; PMCID: PMC11364440.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants. J Prev Alzheimers Dis. 2024; 11(2):294-302. Erickson CM, Karlawish J, Grill JD, Harkins K, Landau SM, Rivera-Mindt MG, Okonkwo O, Petersen RC, Aisen PS, Weiner MW, Largent EA. PMID: 38374735; PMCID: PMC10883638.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    74. Alzheimer's Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners. J Prev Alzheimers Dis. 2024; 11(2):285-293. Cox CG, Salazar CR, Birnbaum AI, Witbracht M, Tam SP, Thai GT, Sajjadi SA, Gillen DL, Grill JD. PMID: 38374734; PMCID: PMC12186707.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Effects of informant replacement in Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2023 Oct-Dec; 9(4):e12439. Nishida MK, Nuño MM, Grill JD, Gillen DL. PMID: 38093736; PMCID: PMC10716564.
      View in: PubMed   Mentions: 3  
    76. Retention of American Indian and Alaska Native participants in the National Alzheimer's Coordinating Center Uniform Data Set. Alzheimers Dement. 2024 03; 20(3):1601-1613. Conniff KR, Grill JD, Gillen DL. PMID: 38053483; PMCID: PMC10984415.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Estimating attrition in mild-to-moderate Alzheimer's disease and mild cognitive impairment clinical trials. Alzheimers Res Ther. 2023 11 21; 15(1):203. Ritchie M, Gillen DL, Grill JD. PMID: 37990339; PMCID: PMC10662394.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    78. Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease. Ann Neurol. 2024 02; 95(2):288-298. Grill JD, Flournoy C, Dhadda S, Ernstrom K, Sperling R, Molina-Henry D, Tranotti K, Harris R, Kanekiyo M, Gee M, Irizarry M, Kramer L, Aisen P, Raman R. PMID: 37830926; PMCID: PMC11733864.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    79. Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection. Alzheimers Dement. 2024 02; 20(2):846-857. Aaronson A, Ashford MT, Jin C, Bride J, Decker J, DeNicola A, Turner RW, Conti C, Tank R, Truran D, Camacho MR, Fockler J, Flenniken D, Ulbricht A, Grill JD, Rabinovici G, Carrillo MC, Mackin RS, Weiner MW, Nosheny RL. PMID: 37797205; PMCID: PMC10916998.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. Remaining Questions in a Brave New World of Alzheimer's Disease Care. Am J Geriatr Psychiatry. 2024 01; 32(1):55-57. Grill JD. PMID: 37704458.
      View in: PubMed   Mentions: 2     Fields:    
    81. Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials. Alzheimers Dement. 2023 09; 19(9):4270-4275. Rahman-Filipiak A, Bolton C, Grill JD, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler NR, Rosen A, Lingler J, Wijsman E, Clark L, Advisory Group on Risk Evidence Education in Dementia (AGREED). PMID: 37450489; PMCID: PMC10530125.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    82. Research Attitude and Interest among Cancer Survivors with or without Cognitive Impairment. Cancers (Basel). 2023 Jun 29; 15(13). Ng DQ, Chan D, Acharya MM, Grill JD, Chan A. PMID: 37444519; PMCID: PMC10340755.
      View in: PubMed   Mentions: 3  
    83. Frameworks for estimating causal effects in observational settings: comparing confounder adjustment and instrumental variables. BMC Med Res Methodol. 2023 05 22; 23(1):122. Zawadzki RS, Grill JD, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative. PMID: 37217854; PMCID: PMC10201752.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    84. Asian Americans' and Pacific Islanders' preferences in recruitment strategies and messaging for participation in the CARE registry: A discrete choice experiment. Alzheimers Dement. 2023 11; 19(11):5198-5208. Ta Park VM, Grill JD, Tsoh J, Meyer OL, Ameli N, Helman S, Tzuang M, Nam B, Hinton L, Kanaya A, Gallagher-Thompson D, Vuong Q, Bang J, Shin HW, Gansky SA. PMID: 37171018; PMCID: PMC12139519.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    85. Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Alzheimers Res Ther. 2023 05 02; 15(1):88. Kirn DR, Grill JD, Aisen P, Ernstrom K, Gale S, Heidebrink J, Jicha G, Jimenez-Maggiora G, Johnson L, Peskind E, McCann K, Shaffer E, Sultzer D, Wang S, Sperling R, Raman R. PMID: 37131229; PMCID: PMC10152012.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    86. Recruitment across two decades of NIH-funded Alzheimer's disease clinical trials. Alzheimers Res Ther. 2023 02 02; 15(1):28. Ritchie M, Gillen DL, Grill JD. PMID: 36732846; PMCID: PMC9893207.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Neurology. 2023 05 23; 100(21):1010-1019. Largent EA, Grill JD, O'Brien K, Wolk D, Harkins K, Karlawish J. PMID: 36720642; PMCID: PMC10238153.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    88. Retention of Study Partners in Longitudinal Studies of Alzheimer Disease. J Alzheimers Dis. 2023; 94(1):189-199. Bollinger RM, Gabel M, Coble DW, Chen SW, Keleman AA, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. PMID: 37212114; PMCID: PMC10515740.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    89. Cohort Effects in Alzheimer's Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer's Disease Cooperative Study. J Prev Alzheimers Dis. 2023; 10(3):471-477. Birnbaum AI, Grill JD, Gillen DL. PMID: 37357287; PMCID: PMC13489100.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. US Adults' Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging. J Prev Alzheimers Dis. 2023; 10(1):34-40. Cox CG, Davis MA, Grill JD, Roberts JS. PMID: 36641608; PMCID: PMC9579667.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    91. Research attitudes in families of individuals with Down syndrome: importance for clinical trials. Alzheimers Res Ther. 2022 11 23; 14(1):176. Lott IT, Kirby KA, Doran E, Grill JD. PMID: 36419175; PMCID: PMC9686118.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    92. Deciding with Others: Interdependent Decision-Making. Hastings Cent Rep. 2022 11; 52(6):23-32. Largent EA, Clapp J, Blumenthal-Barby JS, Grady C, McGuire AL, Karlawish J, Grill JD, Stites SD, Peterson A. PMID: 36537275; PMCID: PMC9773484.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    93. What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials? JAMA Neurol. 2022 11 01; 79(11):1097-1098. Grill JD, Sperling RA, Raman R. PMID: 35969392.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    94. Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care. Neurology. 2022 11 29; 99(22):987-994. Gale SA, Heidebrink J, Grill J, Graff-Radford J, Jicha GA, Menard W, Nowrangi M, Sami S, Sirivong S, Walter S, Karlawish J. PMID: 36180237; PMCID: PMC9728033.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    95. Economic hardships of Korean American family caregivers of persons with dementia: a mixed-methods study. Aging Ment Health. 2023 Sep-Oct; 27(9):1762-1769. Lee K, Seo CH, Cassidy J, Shin HW, Grill JD. PMID: 36120839.
      View in: PubMed   Mentions: 1     Fields:    
    96. Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts. Alzheimer Dis Assoc Disord. 2022 Oct-Dec 01; 36(4):281-287. Gabel M, Bollinger RM, Knox M, Coble DW, Grill JD, Edwards DF, Stark SL, Lingler JH. PMID: 35796752; PMCID: PMC9712497.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    97. Disclosing Alzheimer Disease Biomarker Results to Research Participants. JAMA Neurol. 2022 07 01; 79(7):645-646. Grill JD, Karlawish J. PMID: 35666532.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    98. Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial. Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01; 36(3):192-199. Hakhu NR, Gillen DL, Grill JD, Alzheimer’s Disease Cooperative Study. PMID: 35482891; PMCID: PMC9420751.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research. Alzheimers Dement. 2023 02; 19(2):433-443. Ta Park VM, Meyer OL, Tsoh JY, Kanaya AM, Tzuang M, Nam B, Vuong Q, Bang J, Hinton L, Gallagher-Thompson D, Grill JD. PMID: 35420258; PMCID: PMC9562598.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    100. Symptoms of obstructive sleep apnea are associated with less frequent exercise and worse subjective cognitive function across adulthood. Sleep. 2022 03 14; 45(3). Chappel-Farley MG, Mander BA, Neikrug AB, Stehli A, Nan B, Grill JD, Yassa MA, Benca RM. PMID: 34604910; PMCID: PMC8919199.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    101. Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing. Alzheimers Dement. 2022 10; 18(10):1969-1979. Ketchum FB, Chin NA, Grill J, Gleason CE, Erickson C, Clark LR, Paulsen JS, Kind AJH. PMID: 35213786; PMCID: PMC9402800.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    102. You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research. J Alzheimers Dis. 2022; 90(3):1021-1033. Largent EA, Bhardwaj T, Clapp JT, Sykes OS, Harkins K, Grill JD. PMID: 35311710; PMCID: PMC9482665.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    103. Retaining Participants in Longitudinal Studies of Alzheimer's Disease. J Alzheimers Dis. 2022; 87(2):945-955. Gabel M, Bollinger RM, Coble DW, Grill JD, Edwards DF, Lingler JH, Chin E, Stark SL. PMID: 35404282; PMCID: PMC9673904.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    104. Diversifying Recruitment Registries: Considering Neighborhood Health Metrics. J Prev Alzheimers Dis. 2022; 9(1):119-125. Grill JD, Kind A, Hoang D, Gillen DL. PMID: 35098982; PMCID: PMC8903055.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time? J Alzheimers Dis. 2022; 90(3):963-966. Galasko DR, Grill JD, Lingler JH, Heidebrink JL, Symptomatic Subcommittee of the Advisory Group on Risk Evidence Education for Dementia (AGREEDementi. PMID: 35147543.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    106. Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study. J Alzheimers Dis. 2022; 87(4):1557-1566. Salazar CR, Ritchie M, Gillen DL, Grill JD. PMID: 35491778; PMCID: PMC9277665.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    107. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All. J Alzheimers Dis. 2022; 90(3):953-962. Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT, members of AGREEDementia. PMID: 35938255; PMCID: PMC9901285.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    108. Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials. J Alzheimers Dis. 2022; 90(3):1291-1300. Ritchie M, Witbracht M, Nuño MM, Hoang D, Gillen DL, Grill JD. PMID: 36245381.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. Alzheimer's Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer's Clinical Trial Consortium Sites. J Prev Alzheimers Dis. 2022; 9(4):665-671. Rhodus EK, Aisen P, Grill JD, Rentz DM, Petersen RC, Sperling RA, Salloway SP, Pierce D, Raman R. PMID: 36281670; PMCID: PMC9491649.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    110. Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report. J Prev Alzheimers Dis. 2022; 9(3):388-392. Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R. PMID: 35841239; PMCID: PMC9098373.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    111. Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults. J Prev Alzheimers Dis. 2022; 9(2):286-296. Lewis CK, Bernstein OM, Grill JD, Gillen DL, Sultzer DL. PMID: 35543002.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    112. Online seminars as an information source for direct-to-consumer stem cell therapy. Regen Med. 2022 02; 17(2):81-90. Hassoun M, Golub S, Greenfield S, Grill JD, Cummings BJ. PMID: 34949108; PMCID: PMC10694786.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    113. Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers. Alzheimers Dement (N Y). 2021; 7(1):e12213. Roberts JS, Ferber R, Blacker D, Rumbaugh M, Grill JD, Advisory Group on Risk Evidence Education for Dementia (AGREED). PMID: 34692986; PMCID: PMC8515553.
      View in: PubMed   Mentions: 22  
    114. The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA. Nat Rev Neurol. 2021 09; 17(9):523-524. Karlawish J, Grill JD. PMID: 34267383.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    115. On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomes. Clin Trials. 2021 12; 18(6):714-723. Nuño MM, Grill JD, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative. PMID: 34325548; PMCID: PMC8595611.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. Asian Americans and Pacific Islanders' perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research. Alzheimers Dement (N Y). 2021; 7(1):e12195. Ta Park V, Grill JD, Zhu J, Nguyen K, Nam B, Tsoh J, Kanaya A, Vuong Q, Bang J, Nguyen NCY, Cho IH, Gallagher-Thompson D, Hinton L, Meyer OL. PMID: 34295961; PMCID: PMC8288079.
      View in: PubMed   Mentions: 14  
    117. Reasons for undergoing amyloid imaging among cognitively unimpaired older adults. Ann Clin Transl Neurol. 2021 08; 8(8):1646-1655. Ryan MM, Gillen DL, Grill JD. PMID: 34227249; PMCID: PMC8351390.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    118. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA Netw Open. 2021 07 01; 4(7):e2114364. Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JD. PMID: 34228129; PMCID: PMC8261604.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    119. Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials. Neurology. 2021 09 07; 97(10):496-500. Grill JD, Karlawish J. PMID: 34088880; PMCID: PMC8448555.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    120. Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment. Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01; 35(2):141-147. Ryan MM, Cox CG, Witbracht M, Hoang D, Gillen DL, Grill JD. PMID: 33060367; PMCID: PMC8044253.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    121. Pilot study of an Alzheimer's disease risk assessment program in a primary care setting. Alzheimers Dement (Amst). 2021; 13(1):e12157. Korthauer LE, Denby C, Molina D, Wanjiku J, Daiello LA, Drake JD, Grill JD, Ott BR. PMID: 33665347; PMCID: PMC7896638.
      View in: PubMed   Mentions: 3  
    122. Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout. Clin Trials. 2021 04; 18(2):237-244. Stites SD, Turner RS, Gill J, Gurian A, Karlawish J, Grill JD, Alzheimer’s Disease Cooperative Study. PMID: 33426901; PMCID: PMC8009810.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    123. Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials. Alzheimers Res Ther. 2021 01 08; 13(1):16. Bernstein OM, Grill JD, Gillen DL. PMID: 33419457; PMCID: PMC7791680.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    124. Direct Mail Recruitment to a Potential Participant Registry. Alzheimer Dis Assoc Disord. 2021 Jan-Mar 01; 35(1):80-83. Gombosev A, Salazar CR, Hoang D, Cox CG, Gillen DL, Grill JD. PMID: 31821186; PMCID: PMC7280074.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    125. A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE ε4 Carriers. J Nutr Health Aging. 2021; 25(10):1167-1178. Fote GM, Geller NR, Reyes-Ortiz AM, Thompson LM, Steffan JS, Grill JD. PMID: 34866144; PMCID: PMC8890439.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    126. The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program. J Prev Alzheimers Dis. 2021; 8(3):286-291. Berkness T, Carrillo MC, Sperling R, Petersen R, Aisen P, Flournoy C, Snyder H, Raman R, Grill JD. PMID: 34101785; PMCID: PMC8019089.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    127. Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data. J Prev Alzheimers Dis. 2021; 8(3):257-262. Amariglio RE, Sikkes SAM, Marshall GA, Buckley RF, Gatchel JR, Johnson KA, Rentz DM, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge KC, Sims JR, Grill JD, Aisen PS, Sperling RA. PMID: 34101781; PMCID: PMC8240963.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    128. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment? J Prev Alzheimers Dis. 2021; 8(1):52-58. Cox CG, Ryan MM, Gillen DL, Grill JD. PMID: 33336225; PMCID: PMC8112206.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    129. Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. JAMA Neurol. 2020 12 01; 77(12):1504-1513. Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J, A4 Study Team. PMID: 32777010; PMCID: PMC7418046.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    130. Education and Message Framing Increase Willingness to Undergo Research Lumbar Puncture: A Randomized Controlled Trial. Front Med (Lausanne). 2020; 7:493. Witbracht MG, Bernstein OM, Lin V, Salazar CR, Sajjadi SA, Hoang D, Cox CG, Gillen DL, Grill JD. PMID: 33043024; PMCID: PMC7530193.
      View in: PubMed   Mentions: 8  
    131. Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation. Alzheimers Dement (N Y). 2020; 6(1):e12023. Salazar CR, Hoang D, Gillen DL, Grill JD. PMID: 32399482; PMCID: PMC7207155.
      View in: PubMed   Mentions: 36  
    132. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD). J Prev Alzheimers Dis. 2020; 7(4):219-225. Walter S, Clanton TB, Langford OG, Rafii MS, Shaffer EJ, Grill JD, Jimenez-Maggiora GA, Sperling RA, Cummings JL, Aisen PS. PMID: 32920623; PMCID: PMC7842199.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    133. Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials. Alzheimers Res Ther. 2019 11 27; 11(1):92. Nuño MM, Gillen DL, Grill JD, Alzheimer’s Disease Cooperative Study. PMID: 31775871; PMCID: PMC6881999.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    134. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy. Alzheimers Res Ther. 2019 10 18; 11(1):85. Ryan MM, Grill JD, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative. PMID: 31627738; PMCID: PMC6800492.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    135. Retention of Alzheimer Disease Research Participants. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):299-306. Grill JD, Kwon J, Teylan MA, Pierce A, Vidoni ED, Burns JM, Lindauer A, Quinn J, Kaye J, Gillen DL, Nan B. PMID: 31567302; PMCID: PMC6878201.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    136. Public Understanding and Opinions regarding Genetic Research on Alzheimer's Disease. Public Health Genomics. 2018; 21(5-6):228-237. Kent S, Bardach SH, Zhang X, Abner EL, Grill JD, Jicha GA. PMID: 31326966; PMCID: PMC6932626.
      View in: PubMed   Mentions: 3     Fields:    
    137. Response to "Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure". Alzheimers Res Ther. 2019 06 04; 11(1):51. Grill JD, Cox CG, Harkins K, Karlawish J. PMID: 31159857; PMCID: PMC6547540.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    138. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials? Alzheimer Dis Assoc Disord. 2019 Apr-Jun; 33(2):104-112. Grill JD, Nuño MM, Gillen DL, Alzheimer’s Disease Neuroimaging Initiative. PMID: 30958413; PMCID: PMC6538436.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    139. Recruiting the Oldest-old for Clinical Research. Alzheimer Dis Assoc Disord. 2019 Apr-Jun; 33(2):160-162. Melikyan ZA, Greenia DE, Corrada MM, Hester MM, Kawas CH, Grill JD. PMID: 29734262; PMCID: PMC6289893.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    140. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimers Res Ther. 2018 12 22; 10(1):125. Grill JD, Cox CG, Harkins K, Karlawish J. PMID: 30579361; PMCID: PMC6303934.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    141. A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. Am J Geriatr Psychiatry. 2019 03; 27(3):322-332. Cox CG, Ryan B A MM, Gillen DL, Grill JD. PMID: 30522811; PMCID: PMC6387840.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    142. Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32(4):366-368. Pierce AL, Cox CG, Nguyen HT, Hoang D, Witbracht M, Gillen DL, Grill JD. PMID: 29683808; PMCID: PMC6195861.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimers Res Ther. 2018 09 27; 10(1):101. Largent EA, Karlawish J, Grill JD. PMID: 30261910; PMCID: PMC6161465.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    144. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018 10 01; 111:118-121. Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. PMID: 30006299.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    145. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. J Alzheimers Dis. 2018; 63(3):1055-1063. Grill JD, Hoang D, Gillen DL, Cox CG, Gombosev A, Klein K, O'Leary S, Witbracht M, Pierce A. PMID: 29710723.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    146. Study partners should be required in preclinical Alzheimer's disease trials. Alzheimers Res Ther. 2017 Dec 06; 9(1):93. Grill JD, Karlawish J. PMID: 29212555; PMCID: PMC5719524.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    147. Attitudes toward clinical trials across the Alzheimer's disease spectrum. Alzheimers Res Ther. 2017 Oct 04; 9(1):81. Nuño MM, Gillen DL, Dosanjh KK, Brook J, Elashoff D, Ringman JM, Grill JD. PMID: 28978335; PMCID: PMC5628443.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    148. Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimers Dement (N Y). 2017 Jun; 3(2):205-212. Grill JD. PMID: 28439532; PMCID: PMC5399544.
      View in: PubMed   Mentions: 15  
    149. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017 May 04; 9(1):35. Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J. PMID: 28472970; PMCID: PMC5418690.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    150. Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):135-140. Boise L, Hinton L, Rosen HJ, Ruhl MC, Dodge H, Mattek N, Albert M, Denny A, Grill JD, Hughes T, Lingler JH, Morhardt D, Parfitt F, Peterson-Hazan S, Pop V, Rose T, Shah RC. PMID: 27779492; PMCID: PMC5403614.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    151. Patient and caregiver reactions to clinical amyloid imaging. Alzheimers Dement. 2017 Aug; 13(8):924-932. Grill JD, Cox CG, Kremen S, Mendez MF, Teng E, Shapira J, Ringman JM, Apostolova LG. PMID: 28174068; PMCID: PMC5544590.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    152. Attitudes toward Potential Participant Registries. J Alzheimers Dis. 2017; 56(3):939-946. Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. PMID: 28106553; PMCID: PMC5533604.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    153. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):19-26. Chang TS, Teng E, Elashoff D, Grill JD, Alzheimer’s Disease Neuroimaging Initiative. PMID: 27196535; PMCID: PMC5116001.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    154. Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care. Alzheimers Dement (Amst). 2016; 5:15-22. Apostolova LG, Haider JM, Goukasian N, Rabinovici GD, Chételat G, Ringman JM, Kremen S, Grill JD, Restrepo L, Mendez MF, Silverman DH. PMID: 28054024; PMCID: PMC5198877.
      View in: PubMed   Mentions: 24  
    155. African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2017 Jan; 3(1):57-64. Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. PMID: 29067319; PMCID: PMC5651355.
      View in: PubMed   Mentions: 67  
    156. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. Am J Geriatr Psychiatry. 2017 Mar; 25(3):297-307. Lin A, Brook J, Grill JD, Teng E. PMID: 27818119; PMCID: PMC5316499.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    157. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiol Aging. 2016 Mar; 39:147-53. Grill JD, Zhou Y, Elashoff D, Karlawish J. PMID: 26923411; PMCID: PMC4773920.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    158. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. JAMA Neurol. 2015 Nov; 72(11):1324-33. Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM. PMID: 26414022.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    159. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):364. Grill JD, Karlawish J. PMID: 26485500; PMCID: PMC4648644.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    160. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):350-2. Grill JD, Vinters HV, Monsell SE. PMID: 25973910; PMCID: PMC4643424.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    161. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):50. Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM, Dominantly Inherited Alzheimer’s Network. PMID: 26203303; PMCID: PMC4511231.
      View in: PubMed   Mentions: 10     Fields:    
    162. Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Dis Assoc Disord. 2015 Jul-Sep; 29(3):242-8. Grill JD, Zhou Y, Karlawish J, Elashoff D. PMID: 25551863; PMCID: PMC4486637.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    163. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimers Res Ther. 2015; 7(1):39. Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. PMID: 26120368; PMCID: PMC4481112.
      View in: PubMed   Mentions: 17     Fields:    
    164. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimers Res Ther. 2015; 7(1):43. Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. PMID: 26120369; PMCID: PMC4481070.
      View in: PubMed   Mentions: 18     Fields:    
    165. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimers Res Ther. 2015; 7(1):26. Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. PMID: 25969699; PMCID: PMC4428104.
      View in: PubMed   Mentions: 69     Fields:    
    166. Unmet needs of caregivers of individuals referred to a dementia care program. J Am Geriatr Soc. 2015 Feb; 63(2):282-9. Jennings LA, Reuben DB, Evertson LC, Serrano KS, Ercoli L, Grill J, Chodosh J, Tan Z, Wenger NS. PMID: 25688604; PMCID: PMC4332558.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    167. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Dis Assoc Disord. 2015 Jan-Mar; 29(1):70-4. Cary MS, Rubright JD, Grill JD, Karlawish J. PMID: 24805971; PMCID: PMC4223007.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    168. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dement Geriatr Cogn Disord. 2015; 39(1-2):12-24. Hsiao JJ, Lu PH, Grill JD, Teng E. PMID: 25300404; PMCID: PMC4312538.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    169. Does study partner type impact the rate of Alzheimer's disease progression? J Alzheimers Dis. 2014; 38(3):507-14. Grill JD, Zhou Y, Karlawish J, Elashoff D. PMID: 23985417; PMCID: PMC3842422.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    170. Facilitating Alzheimer disease research recruitment. Alzheimer Dis Assoc Disord. 2014 Jan-Mar; 28(1):1-8. Grill JD, Galvin JE. PMID: 24322484; PMCID: PMC3945167.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    171. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiol Aging. 2014 Mar; 35(3):466-71. Grill JD, Monsell SE. PMID: 24119546; PMCID: PMC3864603.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    172. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemp Clin Trials. 2013 Sep; 36(1):256-62. Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. PMID: 23876673; PMCID: PMC3858206.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    173. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin. 2013; 2:827-35. Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. PMID: 24179834; PMCID: PMC3777716.
      View in: PubMed   Mentions: 19     Fields:    
    174. Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegener Dis Manag. 2013 Feb; 3(1):43-51. Grill JD, Johnson DK, Burns JM. PMID: 25285157; PMCID: PMC4184474.
      View in: PubMed   Mentions: 25     Fields:    
    175. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 2013 Jan 15; 80(3):282-8. Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. PMID: 23255824; PMCID: PMC3589183.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    176. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimers Dement. 2013 May; 9(3):356-359.e1. Grill JD, Karlawish J, Elashoff D, Vickrey BG. PMID: 23141383; PMCID: PMC3572336.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    177. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dement Geriatr Cogn Disord. 2012; 33(5):334-40. Grill JD, Monsell S, Karlawish J. PMID: 22759982; PMCID: PMC3477789.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    178. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging. 2013 Jan; 34(1):62-72. Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D, Alzheimer's Disease Neuroimaging Initiative. PMID: 22503160; PMCID: PMC3412892.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    179. Should persons with autosomal dominant AD be included in clinical trials? Alzheimers Res Ther. 2011 May 23; 3(3):18. Grill JD, Ringman JM. PMID: 21609419; PMCID: PMC3226307.
      View in: PubMed   Mentions: 1     Fields:    
    180. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther. 2010 Dec 21; 2(6):34. Grill JD, Karlawish J. PMID: 21172069; PMCID: PMC3031880.
      View in: PubMed   Mentions: 117     Fields:    
    181. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother. 2010 May; 10(5):711-28. Grill JD, Cummings JL. PMID: 20420492; PMCID: PMC4140224.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsPHPublic Health
    182. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimers Dement. 2009 Mar; 5(2):166-71. Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. PMID: 19328453; PMCID: PMC2746429.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    183. Recognizing involuntary emotional expression disorder. J Neurosci Nurs. 2007 Aug; 39(4):202-7. Robinson-Smith G, Grill JD. PMID: 17847666.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    184. Dendritic stability in a model of adult-onset IGF-I deficiency. Growth Horm IGF Res. 2005 Oct; 15(5):337-48. Grill JD, Sonntag WE, Riddle DR. PMID: 16143551.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    185. Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Res. 2002 May 24; 937(1-2):8-21. Grill JD, Riddle DR. PMID: 12020857.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    186. Transient analgesia evoked by noxious stimulus offset. J Neurophysiol. 2002 Apr; 87(4):2205-8. Grill JD, Coghill RC. PMID: 11929939.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    Joshua's Networks
    Concepts (264)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (76)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California